Beihai Gofar Chuanshan Biological Co., Ltd. (SHA:600538)

SHA:600538 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	128.25	144.84	155.26	170.86	190.4	211.35
Trading Asset Securities	-	-	-	-	-	16.15
Cash & Short-Term Investments	128.25	144.84	155.26	170.86	190.4	227.5
Cash Growth	-4.12%	-6.71%	-9.13%	-10.27%	-16.31%	-2.07%
Accounts Receivable	267.47	254.08	270.94	272.02	210.43	187.81
Other Receivables	2.55	2.15	3.71	2.71	9.24	15.76
Receivables	270.02	256.23	274.65	274.74	219.67	203.57
Inventory	82.07	82.94	80	84.92	73.19	57.55
Prepaid Expenses	-	1.04	1.08	1.94	0.01	0.58
Other Current Assets	6.61	6.32	8.13	10.8	25.56	18.42
Total Current Assets	486.95	491.36	519.12	543.26	508.82	507.61
Property, Plant & Equipment	146.23	148.34	118.25	119.11	117.62	102.19
Long-Term Investments	110.26	108.65	134.06	141.42	107.31	101.28
Goodwill	138.46	138.46	198.67	254.1	254.1	254.1
Other Intangible Assets	26.92	27.29	27.78	28.91	30.22	31.44
Long-Term Accounts Receivable	2.82	4.98	9.72	2.52	2.88	3.21
Long-Term Deferred Tax Assets	5.76	5.62	4.15	3.96	3.33	2.79
Long-Term Deferred Charges	5.32	5.12	6.18	6.05	7.31	8.45
Other Long-Term Assets	38.22	36.93	37.6	42.84	51.19	54.64
Total Assets	960.94	966.75	1,056	1,142	1,083	1,066
Accounts Payable	80.7	72.39	74.01	67.27	59.92	51.2
Accrued Expenses	3.13	14.89	15.47	22.04	12.09	11.59
Short-Term Debt	0.95	0.95	7.34	10	1	-
Current Portion of Leases	5.21	5.22	2.96	1.67	2.89	-
Current Income Taxes Payable	5.56	0.58	1.13	1.39	2.14	5.34
Current Unearned Revenue	11.04	18.68	20.89	38.29	37.58	28.28
Other Current Liabilities	27.64	29.23	46.76	37.63	41.72	117.04
Total Current Liabilities	134.23	141.95	168.57	178.29	157.34	213.45
Long-Term Leases	33.64	35.43	5.51	2.85	2.57	-
Long-Term Deferred Tax Liabilities	1.96	1.98	2.14	1.05	0.26	0.69
Total Liabilities	169.82	179.36	176.22	182.2	160.16	214.15
Common Stock	524.2	524.2	524.2	524.2	524.2	511.77
Additional Paid-In Capital	784.88	784.88	784.88	784.88	784.88	735.51
Retained Earnings	-529.45	-532.59	-438.74	-356.43	-391.28	-401.76
Comprehensive Income & Other	-1.1	-1.1	-1.1	-1.1	-1.1	-1.1
Total Common Equity	778.53	775.39	869.24	951.55	916.7	844.42
Minority Interest	12.59	12	10.07	8.42	5.91	7.15
Shareholders' Equity	791.12	787.39	879.3	959.96	922.61	851.56
Total Liabilities & Equity	960.94	966.75	1,056	1,142	1,083	1,066
Total Debt	39.8	41.6	15.81	14.52	6.46	-
Net Cash (Debt)	88.44	103.24	139.45	156.34	183.95	227.5
Net Cash Growth	-24.97%	-25.97%	-10.80%	-15.01%	-19.14%	-2.07%
Net Cash Per Share	0.20	0.20	0.27	0.31	0.35	0.50
Filing Date Shares Outstanding	524.2	524.2	524.2	524.2	524.2	511.77
Total Common Shares Outstanding	524.2	524.2	524.2	524.2	524.2	511.77
Working Capital	352.72	349.41	350.55	364.97	351.49	294.16
Book Value Per Share	1.49	1.48	1.66	1.82	1.75	1.65
Tangible Book Value	613.15	609.64	642.79	668.54	632.39	558.88
Tangible Book Value Per Share	1.17	1.16	1.23	1.28	1.21	1.09
Buildings	-	131.26	130.11	129.91	120.3	107.81
Machinery	-	138.09	133.43	131.06	126.39	122.34
Construction In Progress	-	1.96	4.82	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.